Msa Safety Inc's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Msa Safety Inc's ROA in the third quarter of 2026?
Msa Safety Inc achieved a return on average assets (ROA) of 10.99 % in its third quarter of 2026, this is above MSA's average return on assets of 6.83%.
Msa Safety Incs assets during the 12 months ending in the third quarter of 2026 are valued at $2 billion

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 89 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 540, from total ROA ranking in the second quarter of 2026 at 610.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	28.38 %	2.01 %	14.67 %	15.84 %	13.9 %
Y / Y Net Income Change	-16.11 %	37.31 %	19.57 %	-1.15 %	4.45 %
Net Income (TTM) in million	303	314	291	279	280
Return On Assets (TTM)	10.99 %	12.2 %	11.35 %	11.25 %	11.71 %
MSA's Total Ranking	# 540	# 610	# 512	# 474	# 434
Total Assets (TTM) in million	3,278	2,602	2,564	2,577	2,554
Seq. Total Assets Change	26.02 %	1.46 %	-0.5 %	0.91 %	0.13 %
Seq. Net Income Change	-32.25 %	20.94 %	-18.02 %	24.88 %	10.9 %

MSA's 5 Years Annual ROA >> Back to MSA Management Effectiveness >> Compare MSA ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 24
Sector	# 90
Overall	# 552

Return On Assets Statistics
High	Average	Low
12.86 %	6.83 %	-0.26 %
(Dec 31 2024)		(Mar 31 2023)

Financial Statements
Msa Safety Inc's Assets	$ 3,278 million	MSA's Balance sheet
Msa Safety Inc's Income	$ 58 million	Quarterly MSA's Income Statement
MSA's Income by Division		See MSA's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	15.8 %	1.64 %	-7.29 %	-0.28 %	30.59 %
Total Assets in million	2,554	2,206	2,170	2,341	2,347
Y / Y Net Income Change	-2.12 %	386.43 %	-67.39 %	724.44 %	-82.02 %
Net Income in million	279	285	59	180	22
Annual Return On Assets	10.92 %	12.92 %	2.7 %	7.67 %	0.93 %

MSA's 5 Years Annual ROA >> Back to MSA Management Effectiveness >> Compare MSA ROA to its Competitors

Comment on MSA's ROA in the fiscal year ending 2025

In the fiscal year 2025 Msa Safety Inc's ROA decreased compared to previous year to 10.92 %, due to deterioration of net income -2.12 % to $278.92 million, from $284.97 million a year ago, as MSA's assets were $2,554.37 million.

More Return On Assets Ratios
MSA's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MSA's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MSA's Competitors
Subscribers only: Roa for Msa Safety Inc's Suppliers
Subscribers only: Return On Assets for MSA's Customers

You may also want to know
MSA's Roi	MSA's Inventory Turnover Ratio	MSA's Growth Rates	MSA's Dividend Comparisons
	MSA's Profitability Ratios	MSA's Asset Turnover Ratio	MSA's Dividend Growth
MSA's Roe	MSA's Valuation Ratios	MSA's Financial Strength Ratios	MSA's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Zevra Therapeutics Inc	26.33 %
Caredx Inc	25.74 %
Medpace Holdings Inc	24.47 %
Acadia Pharmaceuticals Inc	21.60 %
Standard Biotools Inc	21.56 %
Eli Lilly And Company	21.24 %
Iradimed Corporation	20.89 %
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %

Date modified: 2026-11-04T15:21:31+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.